DUBLIN–(BUSINESS WIRE)–The “Medical Tourism Market Analysis by Treatment, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global medical tourism market size is estimated to be USD 46.96 billion in 2021 and is expected to witness a CAGR of 10.79% during the forecast period.
This is owing to hassle-free and affordable international travel, growing healthcare expenses in developed countries, stringent reimbursement policies in local services, and need of quality services.
Factors such as supplementary benefits in other countries, advanced technology, sophisticated devices, efficient practitioners, low cost, and better hospitality coupled with personalized care is also boosting the market growth.
However, visa issues, high commissions and scams by middle men, language barriers, documentation issues, and cumbersome insurance reimbursements are expected to hinder the growth.
The medical tourism market report is categorized into the following segments and subsegments:
Medical Tourism Market, By Treatment (Revenue, 2021-2029, USD Billion)
- Dental
- Cosmetic
- Orthopaedic
- Cardiovascular
- Fertility
- Bariatric
- Ophthalmic
- Others
Medical Tourism Market, By Region (Revenue, 2021-2029, USD Billion)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Canopy Growth Corporation (Canada)
- Aurora Cannabis Inc. (Canada)
- MedMen (US)
- Terra Tech Corp. (US)
- Aphria Inc. (Canada)
- VIVO Cannabis Inc. (Canada)
- The Cronos Group (Canada)
- The Cronos Group (Canada)
- Medical Marijuana Inc. (US)
- STENOCARE (Denmark)
- Tikun Olam (Israel)
- Organigram Holdings Inc. (Canada)
- Cresco Labs (US)
- Indiva (Canada)
- Curaleaf Holding Inc. (US)
For more information about this report visit https://www.researchandmarkets.com/r/72w38x
